Industry speaks of benefits of EU's "New Approach"
This article was originally published in Clinica
Executive Summary
The medical devices industry has told European Commissioners that the EU should to "maintain and innovation-friendly approach" for new technology areas needing regulation, such as human tissue-engineered products and medical applications of nanotechnology. Its position was made clear when representatives of the EU medical devices industry association, Eucomed, spoke at a seminar organised by the European Commission.